With Bitcoin consolidating below $90,000, a significant retreat from its October highs, investors are weighing whether this is a strategic entry point or a warning sign. We examine the competing narratives shaping the market's next move.
An unexpected jump in the Producer Price Index for December underscores the stubborn nature of inflation, with rising wholesale costs threatening to ripple through the economy and sustain higher prices for households.
After a punishing year of underperformance and operational setbacks, Baxter International faces a skeptical analyst community. While some see deep value, the consensus remains firmly on hold as the company navigates product challenges and revised guidance.
From post-IPO darling to a stock trading near historic lows, Rivian faces a critical five-year window. With new models on the horizon and a major Volkswagen partnership, analysts see a path to growth—if it can navigate fierce competition and persistent losses.
Morgan Stanley reaffirms its Overweight rating on Nvidia with a $250 price target, citing the company's systemic advantage through its Vera Rubin platform and robust hyperscaler spending, despite acknowledging competitive and demand risks.
While retirement planning often focuses on savings, a critical financial metric—net worth—reveals a more precarious reality for many households. We examine the causes and consequences of negative net worth, offering actionable steps to build a stronger financial foundation.
Mosaic Company's shares have surged over 16% in the past month, reigniting debate among investors. A deep dive into valuation metrics reveals a stark contradiction: while a discounted cash flow model flags the stock as overvalued, its rock-bottom P/E ratio suggests significant upside potential. We break down the numbers and what they mean for long-term investors.
As SpaceX targets a record-shattering IPO for mid-2026, reports indicate Elon Musk is exploring a potential merger with either Tesla or his AI startup, xAI. The move could create a unified tech and industrial behemoth but faces significant regulatory and operational hurdles.
Eli Lilly announces a massive new manufacturing facility in Pennsylvania, part of a strategic pivot by major drugmakers to onshore production amid trade tensions and soaring demand for weight-loss drugs.
The potential nomination of former Fed Governor Kevin Warsh has sent ripples through financial markets, spotlighting his complex history with cryptocurrency—from early-stage investor to critic of Bitcoin as money, and now a proponent of a U.S. digital dollar.
BlackRock has increased its stake in the diversified precious metals miner Sibanye-Stillwater beyond 5%, signaling strong institutional confidence amid a historic rally in gold and platinum group metals. We examine the drivers behind the surge and what it means for investors.
Apple's Q1 earnings showcased blockbuster iPhone revenue of $85.3 billion, yet investor caution prevails amid persistent supply chain constraints and mounting cost pressures that threaten near-term profitability.
Canadian National Railway reported improved revenue and operating income for the fourth quarter of 2025, citing productivity gains and recovery from prior-year port disruptions. However, the company issued a cautious outlook for 2026, forecasting 'flattish' freight volumes as U.S.-Canada trade tensions and a major regulatory review loom.
XPO's dual recognition of driver safety excellence coincides with significant institutional options activity targeting 2026, setting the stage for a pivotal period as the company navigates leadership change and high expectations for its core LTL business.
Waste Management (NYSE:WM) announced a significant 14.5% dividend hike and a new $3 billion share buyback program, signaling confidence in its cash flow strength despite competitive pressures. The move comes as the waste giant continues to invest in renewable natural gas and automation to drive future growth.
Shares of Allison Transmission Holdings (ALSN) have surged over 35% in three months, reigniting a fierce debate among analysts over whether the stock is overvalued or still trading at a deep discount to its future cash flows.
Popular, Inc. (BPOP) shares have rallied following robust 2025 results, driven by higher net interest income, EPS growth, and aggressive shareholder returns via dividends and buybacks. With the stock up nearly 20% in 90 days, investors are weighing whether its current valuation still offers an entry point.
The FDA has cleared Intuitive Surgical's da Vinci 5 robotic system for select complex cardiac procedures, a move that could reshape the landscape of minimally invasive heart surgery and open a significant new market for the industry leader.
French biopharma firm Inventiva (ENXTPA:IVA) has delivered a stunning 126% total return to shareholders over the past year, sharply contrasting with losses over a three-year horizon. As the stock experiences short-term pullbacks, analysts debate whether its current €5.23 price reflects future promise or present hype, with a key drug candidate hanging in the balance.
Verizon Communications posts its strongest customer gains since 2019, bolstered by a key fiber acquisition and a renewed strategic focus under CEO Hans Vestberg, signaling a potential inflection point for the telecom giant.
